Abstract: In one aspect, a system includes a movable barrier operator configured to open and close a movable barrier; at least one ultra-wideband device associated with the movable barrier operator and electrically configured to receive ultra-wideband radio frequency signals; and a processor operatively connected to the at least one ultra-wideband device and configured to use the ultra-wideband radio signals to determine a status of the movable barrier.

Abstract: The specification generally relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4 and R5 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; and intermediates useful in such manufacture.

Abstract: Computer implemented systems and methods for migrating datacenter data include providing a quantity of carriers having a data storage capacity, receiving, by the quantity of carriers, a quantity of data stored in a first data storage system having a first location and including erasure coded data blocks. The quantity of carriers migrates to a second data storage system having a second location; and transmits the quantity of data to the second data storage system.

Abstract: The specification generally relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4 and R5 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; and intermediates useful in such manufacture.

Abstract: In one aspect, an apparatus includes a processor, a touch-enabled display operatively coupled to the processor, and a memory accessible to the processor. The memory bears instructions executable by the processor to execute a handwriting recognition engine automatically without requiring user selection of a handwriting recognition application to start the handwriting recognition engine, receive input from the touch-enabled display, determine whether the input indicates a character, and automatically store the character responsive to a determination that the input indicates a character.

Abstract: An aspect provides a method, including: capturing, using a gesture input component of an information handling device, a user gesture input; processing, using a processor, the captured user gesture input to extract one or more features; comparing, using a processor, the one or more extracted features of the user gesture input to a predetermined gesture input; determining, using a processor, that a confidence level calculated based on the comparing exceeds a lower similarity threshold but does not exceed a higher similarity threshold; and performing an action selected from the group consisting of communicating with the user, and adjusting the gesture input component. Other aspects are described and claimed.

Abstract: The specification generally relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, where R1, R2, R3, R1 and R5 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; and intermediates useful in such manufacture.

Abstract: Methods, computer program products, and systems are presented. The methods include, for instance: input data from the source environment, including application hosting data of each server in the source environment and one or more cloud type of the source environment. Candidate cloud types for target platform are listed and servers of the source environment are screened for eligibility for the migration. The target platform is selected by applying preconfigured selection rules on the application hosting data of each eligible server in the source environment. Migration recommendations for each eligible server in the source environment, including selected cloud type corresponding to the target platform, are produced.

Abstract: An embodiment provides a method, including: operating a sensor of an information handling device to capture location information of a user; determining, using a processor to analyze the location information, a position of a finger of a user relative to a keyboard location; determining, using the processor, a difference between an expected location for the finger and the position of the finger of the user relative to the keyboard location; and offering, using the processor, feedback regarding the difference determined. Other aspects are described and claimed.

Abstract: Methods, computer program products, and systems are presented. The method computer program products, and systems can include, for instance: obtaining radio signal encoded data from one or more radio signal emitting device disposed on one or more fabric item used for thermal insulation by a user; performing data processing using an obtained environmental temperature of the user and one or more thermal characteristic, wherein the one or more thermal characteristic is determined using the radio signal encoded data; and providing one or more output based on the data processing.

Abstract: The specification generally relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4 and R5 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising to substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; and intermediates useful in such manufacture.

Abstract: Apparatuses, methods, and program products are disclosed for controlling appliances. One apparatus includes a processor, and a memory that stores code executable by the processor. The code is executable by the processor to receive control data from an application. The control data corresponds to multiple appliance types. The code is executable by the processor to control a first appliance type of the multiple appliance types as a direct result of receiving the control data. The code is executable by the processor to control a second appliance type of the multiple appliance types as a direct result of receiving the control data.

Abstract: One embodiment provides a method, including: detecting an event; determining, using a processor of a wireless node, one or more other wireless nodes within wireless range; generating, after the event, a packet of data including identifications of the one or more wireless nodes and positional data associated therewith; and transmitting, over a network connection, the packet of data to at least one of the one or more wireless nodes. Other embodiments are described and claimed.

Abstract: A method, system and computer readable program storage device for using augmented reality. In an embodiment, the method comprises determining one or more characteristics of a plurality of users, and determining whether a first and a second user of the plurality of users are in proximity to each other. Responsive to determining that the first and second users are in proximity to each other, determining defined information about the second user is determined; and responsive to determining the defined information of the second user, the defined information is displayed to the first user via an augmented reality display over a security badge associated with the second user. In embodiments, the determining one or more characteristics of a plurality of users includes determining one or more characteristics of the plurality of users based on location, social media, or work profiles.

Abstract: Computer implemented systems and methods for migrating datacenter data include providing a quantity of carriers having a data storage capacity, receiving, by the quantity of carriers, a quantity of data stored in a first data storage system having a first location and including erasure coded data blocks. The quantity of carriers migrates to a second data storage system having a second location; and transmits the quantity of data to the second data storage system.

Abstract: The specification generally relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4 and R5 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising to substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; and intermediates useful in such manufacture.

Abstract: One embodiment provides a method, including: receiving authentication input, at a device, that is sent to an aggregate service device; requesting file system data, retrieved by the aggregate service device, analogous to data stored on a remote device and data stored on a cloud storage device; receiving at the device, after providing the authentication input to the aggregate service device, the file system data from the aggregate service device; and displaying, on the device, a user interface in the form of a file manager application generated from the requested file system data.

Abstract: Methods, computer program products, and systems are presented. The methods include, for instance: input data from the source environment, including application hosting data of each server in the source environment and one or more cloud type of the source environment. Candidate cloud types for target platform are listed and servers of the source environment are screened for eligibility for the migration. The target platform is selected by applying preconfigured selection rules on the application hosting data of each eligible server in the source environment. Migration recommendations for each eligible server in the source environment, including selected cloud type corresponding to the target platform, are produced.

Abstract: One embodiment provides a method, including: sending, from a device, input from a user requesting access to data retrievable by an aggregate service device; sending, from the device, input from the user selecting, from the aggregate service device, a selection of data; and sending a distribution command; wherein the distribution command comprises information related to distributing a pointer indicating the selection of data.

Abstract: The specification generally relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4 and R5 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising to substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; and intermediates useful in such manufacture.